Thursday, 3 August 2017

Size and Share of Sickle Cell Market in Global Industry : Insights, Development, Research and Forecast 2017-2030

ResearchMoz presents professional and in-depth study of "Global Sickle Cell Market: Industry Analysis & Outlook (2020-2030)".

Sickle Cell (SC) is a genetic blood disorder caused by inheriting abnormal hemoglobin (Hb) genes from parents. Normally, red blood cells (RBC) have disc-like shapes which help them to travel throughout the blood vessels. But in the case of SC, red blood cells of a person’s blood take an abnormal sickle-like shape. Due to SC, red blood cells become sticky and inelastic. These RBCs block the blood circulation in different parts of body by getting blocked in the small blood vessels. Red blood cells live for about 120 days but these sickle cells live for only 10-20 days. There are various types of sickle cell disorders caused by different mutations in hemoglobin genes. Although, all types of sickle cell disorder have similar symptoms but they differ in their severity and nature of occurrence.

Currently, sickle cell is affecting approximately 20 to 25 million people worldwide and approximately 300 thousand births occur with sickle cell annually. Sickle cell has a high concentration rate in malaria endemic parts of worlds, especially, African, Middle Eastern and South Asian regions. In many African countries, 10% to 40% population carries sickle cell traits.

The U.S. is expected to be the first region to start the selling of sickle cell drugs due to developing drug therapies and later on, market penetration of sickle cell drugs would occur in Europe.

The global sickle cell market is expected to grow in future due to rising African-American population, economic growth, increasing healthcare expenditure and prevalence of sickle cell. Key trends of this market include progressing drug pipeline and rising research grants. However, there are some factors which can hinder growth of the market including regulatory changes, associated risks and slow adoption of treatments.

Get PDF for more Professional and Technical insights @

The report “Global Sickle Cell Market: Industry Analysis & Outlook (2020-2030)” by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the U.S, and Europe along with the global market. The report profiles key players of the market including Novartis, Bristol-Myers Squibb, Shire Plc, Bluebird Bio and Global Blood Therapeutics Inc.

Table of Content

1. Overview
1.1 Sickle Cell
1.2 Types of Sickle Cell
1.3 Symptoms & Diagnosis
1.4 Treatment

2. Global Market
2.1 Global Sickle Cell Drug Market Forecast by Value
2.2 Sickle Cell Drug Market by Region

Make an Enquiry about TOC @

3. Regional Market
3.1 The U.S.
3.1.1 The U.S. Sickle Cell Drug Market Forecast by Value
3.1.2 The U.S. Sickle Cell Patient Volume Forecast
3.1.3 The U.S. Sickle Cell Treated Patient Volume Forecast
3.1.4 The U.S. Sickle Cell Market Forecast by Treatment Cost
3.2 Europe
3.2.1 Europe Sickle Cell Drug Market Forecast by Value
3.2.2 Europe Sickle Cell Patient Volume Forecast
3.2.3 Europe Sickle Cell Treated Patient Volume Forecast
3.2.4 Europe Sickle Cell Market Forecast by Treatment Cost

4. Market Dynamics
4.1 Growth Drivers
4.1.1 Rising American-African Population
4.1.2 Rising Economic Growth
4.1.3 Increasing Healthcare Expenditure
4.1.4 Increasing Prevalence of Sickle Cell
4.2 Key Trends
4.2.1 Progressing Drug Pipeline
4.2.2 Rising Research Grants
4.3 Challenges
4.3.1 Regulatory Challenges
4.3.2 Associated Risks
4.3.3 Slow Adoption of Treatment

5. Competition
5.1 Global Market
5.1.1 Revenue Comparison of Key Players
5.1.2 Market Cap Comparison of Key Players (2016)

Browse Full Report @

6. Company Profiles
6.1 Novartis
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Bristol-Myers Squibb
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Shire Plc.
6.3.1 Business Overview
6.3.2 Financial Overview

For More Information Kindly Contact:

Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Follow us on LinkedIn @
Follow me on :

No comments:

Post a Comment